Literature DB >> 1714721

Molecular cloning of the human histamine H2 receptor.

I Gantz1, G Munzert, T Tashiro, M Schäffer, L Wang, J DelValle, T Yamada.   

Abstract

We utilized the technique of polymerase chain reaction with oligonucleotide primers based upon the nucleotide sequence of the canine H2 histamine receptor gene which we recently isolated to clone its human homologue. Transfection of a construct of this gene in Colo-320 DM cells led to the expression of a receptor that bound to [methyl-3H] tiotidine and was linked to 3',5'cyclic adenosine monophosphate (cAMP) generation in response to histamine. Both cAMP generation and [methyl-3H] tiotidine binding were inhibited with the H2 histamine receptor selective antagonist cimetidine but not diphenhydramine or thioperamide which are, respectively, H1 and H3 histamine receptor antagonists. These data confirm that we have successfully cloned a novel gene encoding the human H2 histamine receptor.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1714721     DOI: 10.1016/0006-291x(91)91047-g

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  29 in total

1.  Inverse agonism of histamine H2 antagonist accounts for upregulation of spontaneously active histamine H2 receptors.

Authors:  M J Smit; R Leurs; A E Alewijnse; J Blauw; G P Van Nieuw Amerongen; Y Van De Vrede; E Roovers; H Timmerman
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-25       Impact factor: 11.205

Review 2.  Retinopetal axons in mammals: emphasis on histamine and serotonin.

Authors:  Matthew J Gastinger; Ning Tian; Tamas Horvath; David W Marshak
Journal:  Curr Eye Res       Date:  2006 Jul-Aug       Impact factor: 2.424

3.  New nucleotide sequence data on the EMBL File Server.

Authors: 
Journal:  Nucleic Acids Res       Date:  1991-12-11       Impact factor: 16.971

Review 4.  Molecular and biochemical pharmacology of the histamine H4 receptor.

Authors:  Rob Leurs; Paul L Chazot; Fiona C Shenton; Herman D Lim; Iwan J P de Esch
Journal:  Br J Pharmacol       Date:  2009-05       Impact factor: 8.739

5.  Expression of a G protein-coupled receptor (GPCR) leads to attenuation of signaling by other GPCRs: experimental evidence for a spontaneous GPCR constitutive inactive form.

Authors:  Maria Rosario Tubio; Natalia Fernandez; Carlos Patricio Fitzsimons; Sabrina Copsel; Sergio Santiago; Carina Shayo; Carlos Davio; Federico Monczor
Journal:  J Biol Chem       Date:  2010-03-18       Impact factor: 5.157

6.  Structural and functional analysis of the canine histamine H2 receptor by site-directed mutagenesis: N-glycosylation is not vital for its action.

Authors:  Y Fukushima; Y Oka; T Saitoh; H Katagiri; T Asano; N Matsuhashi; K Takata; E van Breda; Y Yazaki; K Sugano
Journal:  Biochem J       Date:  1995-09-01       Impact factor: 3.857

7.  The expression and function of histamine H₃ receptors in pancreatic beta cells.

Authors:  T Nakamura; T Yoshikawa; N Noguchi; A Sugawara; A Kasajima; H Sasano; K Yanai
Journal:  Br J Pharmacol       Date:  2014-01       Impact factor: 8.739

8.  Point mutations in the second extracellular loop of the histamine H2 receptor do not affect the species-selective activity of guanidine-type agonists.

Authors:  Hendrik Preuss; Prasanta Ghorai; Anja Kraus; Stefan Dove; Armin Buschauer; Roland Seifert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-11-13       Impact factor: 3.000

Review 9.  Molecular and cellular analysis of human histamine receptor subtypes.

Authors:  Roland Seifert; Andrea Strasser; Erich H Schneider; Detlef Neumann; Stefan Dove; Armin Buschauer
Journal:  Trends Pharmacol Sci       Date:  2012-12-17       Impact factor: 14.819

10.  Protein kinase C inhibits cyclic adenosine monophosphate generation by histamine and truncated glucagon like peptide 1 in the human gastric cancer cell line HGT-1.

Authors:  P McKenna; J M Williams; C P Gespach; P J Hanson
Journal:  Gut       Date:  1993-07       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.